Can a bladder shield make cancer treatment more tolerable?
NCT ID NCT07495072
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 56 adults with non-muscle-invasive bladder cancer who receive BCG therapy, a standard treatment that often causes painful bladder symptoms. Researchers want to see if giving Blad-Care (a gel that restores the bladder's protective lining) early during BCG treatment works better than waiting until after BCG is done. The goal is to reduce irritation like pain and urgency, helping patients complete their cancer therapy with less discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BCG-INDUCED CYSTITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kyung Hee University Hospital
RECRUITINGSeoul, Dongdaemun-gu, 02447, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Could a simple blood or urine test spot bladder cancer earlier?
- Can heated chemotherapy beat bladder cancer without surgery?
- Can a Two-Drug bladder wash beat cancer recurrence?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Bladder cancer surgery: what happens after the bladder is removed?